SPARC and central nervous system cancer: Furthermore, the lack of coimmunoprecipitation with VEGF and the lack of VEGFR1 on the glioma cells indicate that the decrease in vascularity induced by SPARC is also not because of the inhibition of VEGF-VEGFR1 autocrine signaling in glioma cells.